PET identifies cancer cells as they absorb chemical tracers, and MRI views the surrounding tissue. Philips spokesman Steve Klink compared the PET to a GPS system and MRI to the map.
Related Articles on Medical Devices:
FDA Approves New Boston Scientific Heart Stent
Doctors Question the Value of Robot-Assisted Surgery
FDA’s Dr. Jeffrey Shuren Speaks to Congress About Medical Device Approval
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.